PICHIRI, Isabella
 Distribuzione geografica
Continente #
EU - Europa 3.348
NA - Nord America 2.795
AS - Asia 1.790
SA - Sud America 268
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 8.275
Nazione #
US - Stati Uniti d'America 2.735
GB - Regno Unito 1.310
RU - Federazione Russa 984
SG - Singapore 643
CN - Cina 618
BR - Brasile 218
IT - Italia 216
VN - Vietnam 167
SE - Svezia 164
DE - Germania 151
FR - Francia 136
IE - Irlanda 126
HK - Hong Kong 121
FI - Finlandia 119
KR - Corea 77
CA - Canada 33
UA - Ucraina 32
IN - India 28
ID - Indonesia 27
BD - Bangladesh 22
BE - Belgio 18
JP - Giappone 18
ZA - Sudafrica 18
AR - Argentina 16
ES - Italia 16
MX - Messico 16
NL - Olanda 13
PL - Polonia 13
TR - Turchia 11
EC - Ecuador 10
NG - Nigeria 10
GR - Grecia 8
AZ - Azerbaigian 7
GH - Ghana 7
IQ - Iraq 7
PK - Pakistan 7
PY - Paraguay 7
UZ - Uzbekistan 6
CH - Svizzera 5
CO - Colombia 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
ET - Etiopia 5
LT - Lituania 5
RO - Romania 5
AT - Austria 4
BO - Bolivia 4
DK - Danimarca 4
EG - Egitto 4
JO - Giordania 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CR - Costa Rica 3
IL - Israele 3
JM - Giamaica 3
MY - Malesia 3
PA - Panama 3
SA - Arabia Saudita 3
TN - Tunisia 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
CL - Cile 2
HR - Croazia 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
LV - Lettonia 2
MA - Marocco 2
PE - Perù 2
QA - Qatar 2
UY - Uruguay 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BF - Burkina Faso 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
EE - Estonia 1
EU - Europa 1
HU - Ungheria 1
LS - Lesotho 1
LU - Lussemburgo 1
LY - Libia 1
ML - Mali 1
MN - Mongolia 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 8.273
Città #
Southend 1.199
Moscow 393
Singapore 338
Chandler 321
Ashburn 304
Dallas 244
San Jose 218
Ann Arbor 185
Jacksonville 184
Beijing 144
Dublin 126
Woodbridge 123
Hong Kong 117
Houston 102
Verona 96
Jinan 62
Los Angeles 56
Ho Chi Minh City 55
Wilmington 55
New York 50
The Dalles 49
Nanjing 45
Lawrence 42
Princeton 42
Helsinki 37
Lancaster 36
Munich 34
Shenyang 28
Buffalo 27
Santa Clara 27
Hanoi 26
Orem 24
Seoul 22
São Paulo 21
Dong Ket 20
Tianjin 20
Frankfurt am Main 19
Hebei 19
Brussels 18
Turku 18
Columbus 17
Council Bluffs 17
Jakarta 17
Tokyo 17
Boardman 16
Nanchang 16
Changsha 14
Dearborn 13
Ningbo 13
Redondo Beach 13
Zhengzhou 13
London 12
Milan 12
Kent 11
Montreal 11
Warsaw 11
Johannesburg 10
Phoenix 10
Taizhou 10
Toronto 10
Abuja 9
Cagliari 9
Chennai 9
Redwood City 9
Shanghai 9
Sindelfingen 9
Atlanta 8
Brooklyn 8
Chicago 8
Falls Church 8
Haiphong 8
Hangzhou 8
Nikaia 8
Redmond 8
San Francisco 8
Taiyuan 8
Accra 7
Baku 7
Da Nang 7
Guayaquil 7
Haikou 7
Jiaxing 7
Poplar 7
Rio de Janeiro 7
Ankara 6
Belo Horizonte 6
Detroit 6
Nuremberg 6
Stockholm 6
Tashkent 6
Addis Ababa 5
Barnet 5
Brasília 5
Campinas 5
Düsseldorf 5
Fuzhou 5
Washington 5
Amman 4
Auburn Hills 4
Bologna 4
Totale 5.482
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 778
Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. 260
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial. 249
Glycated haemoglobin is inversely related to serum vitamin d levels in type 2 diabetic patients. 233
Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance 214
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 209
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes. 208
American Diabetes Association - 75th Scientific Meeting; Section: Epidemiology/Genetics; Poster n. 1581-P: "Nonalcoholic Fatty Liver Disease Is Associated with Heart Valve Calcification in Type 2 Diabetes" 205
Primary cutaneous B-cell lymphoma and chronic leg ulcers in a patient with type 2 diabetes 202
Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes 200
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 199
Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes. 197
Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. 196
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 195
NAFLD, diabete tipo 2, malattia cardiovascolare? 195
Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus. 192
Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes 192
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 191
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 190
Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes 189
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 189
'Case of the Month' from the University of Verona, Italy-navigating the medical and surgical challenges of urinary bladder paraganglioma: insights from a clinical case 185
Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring 182
Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program. 182
Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function 180
Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes 180
Associazione tra epatopatia steatosica non alcolica (NAFLD) e malattia renale cronica in pazienti affetti da diabete mellito tipo 1. 173
Hemostatic and fibrinolytic abnormalities in endocrine diseases: a narrative review. [Review] 172
Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus 170
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 170
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic patients. 169
Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. 166
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 154
Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. 153
Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes 150
Relation of elevated serum uric acid levels to first-degree heart block and other cardiac conduction defects in hospitalized patients with type 2 diabetes 149
Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus. 145
Vitamin D, thrombosis, and haemostasis: more than skin deep. [Review] 136
Iperuricemia e rischio cardiovascolare. [Review] 133
Non-alcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. [Review] 126
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. 119
Steatosi epatica non alcolica nel diabete mellito. (Rassegna) 116
Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10 104
Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence? [Review] 104
Totale 8.401
Categoria #
all - tutte 23.630
article - articoli 20.250
book - libri 0
conference - conferenze 2.918
curatela - curatele 0
other - altro 462
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.260


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021141 0 0 0 0 0 0 0 0 0 42 52 47
2021/2022423 51 113 18 16 17 51 4 25 12 6 33 77
2022/2023850 58 106 64 136 66 205 8 63 103 4 17 20
2023/2024439 17 28 37 51 49 86 6 15 3 47 85 15
2024/20251.043 55 54 43 194 73 53 84 41 149 30 90 177
2025/20263.122 209 157 285 533 894 205 274 170 212 183 0 0
Totale 8.401